Guest of Honour Plenary Speakers
Fred Kramer
Professor, New Jersey Medical School Rutgers University | 
Rudi Pauwels
Founder Director/Chief Executive Officer, Biocartis | 
Jean-Luc Butel
Global Healthcare Advisor, President, K8 Global & Senior Advisor , McKinsey&Company | 
Chwee Teck Lim
NUS Society Chair Professor, Department of Biomedical Engineering, Institute for Health Innovation & Technology (iHealthtech), Mechanobiology Institute, National University of Singapore | 
Steven Myint
Senior fellow, Consultant, Adjunct Professor, Chairman, ETPL, Duke-NUS, Inex Private Ltd |
Keynote Speakers
Mahesh Choolani
Research Director , National University Health System (NUHS) | 
Roger Foo
Group Leader, GIS | 
John CW Lim
Executive Director, Centre of Regulatory Excellence, Duke-NUS Medical School Singapore, Deputy Director of Medical Services (Industry & Research Matters) , Ministry of Health | 
Patrick Tan
Professor, Duke-NUS Medical School and Deputy Executive Director, Biomedical Research Council, A*STAR | 
David Wong
Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles |
OverviewSelect Bio and the Diagnostics Development Hub, part of Exploit Technologies Pte. Ltd. present Singapore’s inaugural Diagnostics Summit.
The event will take place on the 13-14 October at the Biopolis, Singapore’s custom built biomedical research and development hub, home to a large number of the world’s leading Life Science organisations and A*STAR research institutes.
Bringing together industry professionals, entrepreneurs, researchers, academia and students, this comprehensive two day meeting will look to address the challenges of translating the latest advances in scientific research into tangible diagnostics solutions.
A key focus for this conference track is to discuss the relative attributes of both Circulating Biomarkers and Tissue-Based Biomarkers for Companion Diagnostics. We will also highlight Emerging Technologies and Services within the Liquid Biopsy space, in addition to discussing Technology Commercialization, the Regulatory Landscape and Market Entry into Asia.
Please see below for a comprehensive list of the subject areas to be addressed.
Agenda Topics- Circulating Biomarkers vs. Tissue-based Biomarkers for Companion Diagnostics Development
- Companion Diagnostics in Various Disease Classes
- Epigenetic Modifications (Hypermethylation of specific genes) as Biomarkers for Diagnostics
- Next-Generation Sequencing (NGS) for Liquid Biopsy Development and Companion Diagnostics
- Protein Biomarkers versus Nucleic Acid Biomarkers for Companion Diagnostics Development
- Therapeutic Potential: Automimmune Diseases, Cancer, Cardiovascular Disease, CNS and Neurodenerative Diseases and Traumatic Brain Injury, Pregnancy and Reproductive Health
- Technology & Company Showcase, Commercialization & the Regulatory Landscape
- Asia/Pacific vs EU vs US Regulatory Landscape and Barriers to Entry
- Company Case Studies
- Emerging Technology Showcase: Companies Highlight Products and Services in the Liquid Biopsy Space
- Transforming your IPs into clinically validated Diagnostic Devices
- Why Singapore?
Sponsorship and Exhibition OpportunitiesPaul Raggett, Exhibition Manager
p.raggett@selectbio.com
+855 6999 5137
|
Distinguished FacultySiew Hwa Ong, CEO, Acumen Research Laboratories
Lihan Zhou, Co Founder/Chief Technology Officer, MiRXES Pte Ltd
Johnson Ng, Founder And CEO, JN Medsys Pte Ltd
Sarah Ng, Post-doctoral Fellow , IMCB
Nat Whitney, President, Whitney Research, Inc
Hwee Ee Tan, Principal Consultant/Director, DH RegSys Pte Ltd
Olli Carpen , Professor of Pathology, Scientific Director , University of Helsinki & Helsinki Biobank
Say Li Kong, Research Associate, Genome Institute of Singapore
Angela Barrett, Research Fellow, National University of Singapore
Jinkai Teo, Scientist, Merck
Winston Koh, Scientist, Stanford University
Richie Soong, Senior Principle Investigator, National University of Singapore
Min-Han Tan, Team Leader, Principal Research Scientist, Institute Of Bioengineering & Nanotechnology A*Star
|
| Corporate Sponsors | Web Sponsors | Offical Journal Partner | Networking |
| |  |  |
|
